Cargando…

Protective effects of muscone on traumatic spinal cord injury in rats

BACKGROUND: Traumatic spinal cord injury (SCI) is a major clinical concern, and it is a life-changing neurological condition with substantial socioeconomic implications. Muscone has been widely used in traditional Chinese medicinal formulations for its anti-inflammatory activity. However, its protec...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Chao, Gui, Fei, Huang, Qian, Luo, Yuanmeng, Zeng, Zili, Li, Ruifu, Guo, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279775/
https://www.ncbi.nlm.nih.gov/pubmed/35845509
http://dx.doi.org/10.21037/atm-22-2672
_version_ 1784746475788435456
author Yu, Chao
Gui, Fei
Huang, Qian
Luo, Yuanmeng
Zeng, Zili
Li, Ruifu
Guo, Liang
author_facet Yu, Chao
Gui, Fei
Huang, Qian
Luo, Yuanmeng
Zeng, Zili
Li, Ruifu
Guo, Liang
author_sort Yu, Chao
collection PubMed
description BACKGROUND: Traumatic spinal cord injury (SCI) is a major clinical concern, and it is a life-changing neurological condition with substantial socioeconomic implications. Muscone has been widely used in traditional Chinese medicinal formulations for its anti-inflammatory activity. However, its protective effects on traumatic SCI have not been explored. This study investigated whether muscone plays a protective role in SCI and compared its effects with those of methylprednisolone sodium succinate (MPSS). METHODS: Rats were divided into five groups: normal saline (NS; n=24), methylprednisolone (MP; w=24), and muscone 1 (MO1), muscone 2 (MO2), and muscone 3 (MO3) (n=24 in each group, collectively called the MOx groups). The SCI rat model was established by the modified Allen’s method. The rats were administered muscone (MO1: 2.5 mg/kg, MO2: 5 mg/kg, and MO3: 10 mg/kg) or MP (30 mg/kg), or an equivalent volume of saline. The rats were kept under observation for 4 weeks. Malondialdehyde (MDA), superoxide dismutase (SOD), interleukin-6 (IL-6), interleukin-1β (IL-1β), and tumor necrosis factor-alpha (TNF-α) levels were detected using enzyme-linked immunosorbent assay (ELISA). The expression of glial fibrillary acidic protein (GFAP), B-cell lymphoma-2 (BCL-2), and caspase3 was detected by western blot analysis. Hematoxylin-eosin (HE), Nissl, and immunocytochemistry (ICC) staining was performed for pathological observation. Basso-Beattie-Bresnahan motor function scores were evaluated for assessment of neural functions after acute SCI. RESULTS: Muscone inhibited immune-inflammatory reactions, neuronal necrosis, and apoptosis. The lower limb function recovery was better in the MOx groups compared with NS and MP groups according to Basso-Beattie-Bresnahan scores. The changes were remarkable in the MO2 group compared with the other groups. CONCLUSIONS: Muscone alleviates secondary injury after SCI by reducing immune-inflammatory reactions, neuronal necrosis, and apoptosis.
format Online
Article
Text
id pubmed-9279775
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-92797752022-07-15 Protective effects of muscone on traumatic spinal cord injury in rats Yu, Chao Gui, Fei Huang, Qian Luo, Yuanmeng Zeng, Zili Li, Ruifu Guo, Liang Ann Transl Med Original Article BACKGROUND: Traumatic spinal cord injury (SCI) is a major clinical concern, and it is a life-changing neurological condition with substantial socioeconomic implications. Muscone has been widely used in traditional Chinese medicinal formulations for its anti-inflammatory activity. However, its protective effects on traumatic SCI have not been explored. This study investigated whether muscone plays a protective role in SCI and compared its effects with those of methylprednisolone sodium succinate (MPSS). METHODS: Rats were divided into five groups: normal saline (NS; n=24), methylprednisolone (MP; w=24), and muscone 1 (MO1), muscone 2 (MO2), and muscone 3 (MO3) (n=24 in each group, collectively called the MOx groups). The SCI rat model was established by the modified Allen’s method. The rats were administered muscone (MO1: 2.5 mg/kg, MO2: 5 mg/kg, and MO3: 10 mg/kg) or MP (30 mg/kg), or an equivalent volume of saline. The rats were kept under observation for 4 weeks. Malondialdehyde (MDA), superoxide dismutase (SOD), interleukin-6 (IL-6), interleukin-1β (IL-1β), and tumor necrosis factor-alpha (TNF-α) levels were detected using enzyme-linked immunosorbent assay (ELISA). The expression of glial fibrillary acidic protein (GFAP), B-cell lymphoma-2 (BCL-2), and caspase3 was detected by western blot analysis. Hematoxylin-eosin (HE), Nissl, and immunocytochemistry (ICC) staining was performed for pathological observation. Basso-Beattie-Bresnahan motor function scores were evaluated for assessment of neural functions after acute SCI. RESULTS: Muscone inhibited immune-inflammatory reactions, neuronal necrosis, and apoptosis. The lower limb function recovery was better in the MOx groups compared with NS and MP groups according to Basso-Beattie-Bresnahan scores. The changes were remarkable in the MO2 group compared with the other groups. CONCLUSIONS: Muscone alleviates secondary injury after SCI by reducing immune-inflammatory reactions, neuronal necrosis, and apoptosis. AME Publishing Company 2022-06 /pmc/articles/PMC9279775/ /pubmed/35845509 http://dx.doi.org/10.21037/atm-22-2672 Text en 2022 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Yu, Chao
Gui, Fei
Huang, Qian
Luo, Yuanmeng
Zeng, Zili
Li, Ruifu
Guo, Liang
Protective effects of muscone on traumatic spinal cord injury in rats
title Protective effects of muscone on traumatic spinal cord injury in rats
title_full Protective effects of muscone on traumatic spinal cord injury in rats
title_fullStr Protective effects of muscone on traumatic spinal cord injury in rats
title_full_unstemmed Protective effects of muscone on traumatic spinal cord injury in rats
title_short Protective effects of muscone on traumatic spinal cord injury in rats
title_sort protective effects of muscone on traumatic spinal cord injury in rats
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279775/
https://www.ncbi.nlm.nih.gov/pubmed/35845509
http://dx.doi.org/10.21037/atm-22-2672
work_keys_str_mv AT yuchao protectiveeffectsofmusconeontraumaticspinalcordinjuryinrats
AT guifei protectiveeffectsofmusconeontraumaticspinalcordinjuryinrats
AT huangqian protectiveeffectsofmusconeontraumaticspinalcordinjuryinrats
AT luoyuanmeng protectiveeffectsofmusconeontraumaticspinalcordinjuryinrats
AT zengzili protectiveeffectsofmusconeontraumaticspinalcordinjuryinrats
AT liruifu protectiveeffectsofmusconeontraumaticspinalcordinjuryinrats
AT guoliang protectiveeffectsofmusconeontraumaticspinalcordinjuryinrats